FDA Inspection 935478 — AbbVie Bioresearch Center

AbbVie Bioresearch Center — FEI 3003684386

The FDA completed an inspection of AbbVie Bioresearch Center on June 11, 2015 in Worcester, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 11, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Worcester, MA (United States)